Search research articles
Contact Us
Filters
Showing results (11-20 of 212) with videos related to
Page
of 22
Sort By:
Hematology (Amsterdam, Netherlands)
|
February 18, 2004
The use of fluorescence in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL)
Alessandro Gozzetti, Rosaria Crupi, Daniela Tozzuoli
Nature Reviews. Clinical Oncology
|
September 6, 2012
Lenalidomide maintenance in myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia
Annals of Hematology
|
July 15, 2009
Cutaneous myeloma and bortezomib
Alessandro Gozzetti, Marzia Defina, Monica Bocchia
Clinical Lymphoma, Myeloma & Leukemia
|
December 4, 2014
Central nervous system multiple myeloma
Alessandro Gozzetti, Alfonso Cerase, Monica Bocchia
Leukemia
|
September 4, 2020
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
Alessandro Gozzetti, Enrico Capochiani, Monica Bocchia
Annals of Hematology
|
January 9, 2016
Central nervous system multiple myeloma
Alessandro Gozzetti, Alfonso Cerase, Monica Bocchia
Cancer
|
October 24, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia
Alessandro Gozzetti, Marzia Defina, Alberto Fabbri
British Journal of Haematology
|
September 30, 2023
Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs
Alessandro Gozzetti, Irene Bernareggi, Vincenzo Sammartano
Nature Reviews. Clinical Oncology
|
November 20, 2013
Treatment of smoldering multiple myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia
Clinical Case Reports
|
December 28, 2020
Daratumumab efficacy in extramedullary orbital myeloma
Alessandro Gozzetti, Alfonso Cerase, Monica Bocchia
Page
of 22
Search research articles
Search
Showing results (11-20 of 212) with videos related to
Sort By:
Page
of 22
Hematology (Amsterdam, Netherlands)
|
February 18, 2004
The use of fluorescence in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL)
Alessandro Gozzetti, Rosaria Crupi, Daniela Tozzuoli
Nature Reviews. Clinical Oncology
|
September 6, 2012
Lenalidomide maintenance in myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia
Annals of Hematology
|
July 15, 2009
Cutaneous myeloma and bortezomib
Alessandro Gozzetti, Marzia Defina, Monica Bocchia
Clinical Lymphoma, Myeloma & Leukemia
|
December 4, 2014
Central nervous system multiple myeloma
Alessandro Gozzetti, Alfonso Cerase, Monica Bocchia
Leukemia
|
September 4, 2020
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
Alessandro Gozzetti, Enrico Capochiani, Monica Bocchia
Annals of Hematology
|
January 9, 2016
Central nervous system multiple myeloma
Alessandro Gozzetti, Alfonso Cerase, Monica Bocchia
Cancer
|
October 24, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia
Alessandro Gozzetti, Marzia Defina, Alberto Fabbri
British Journal of Haematology
|
September 30, 2023
Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs
Alessandro Gozzetti, Irene Bernareggi, Vincenzo Sammartano
Nature Reviews. Clinical Oncology
|
November 20, 2013
Treatment of smoldering multiple myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia
Clinical Case Reports
|
December 28, 2020
Daratumumab efficacy in extramedullary orbital myeloma
Alessandro Gozzetti, Alfonso Cerase, Monica Bocchia
Page
of 22